3 terminated. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Terminated 3 |
| Phase 2 | 2 | Terminated 2 |
Follow Gastric Outlet Obstruction: new trials by email Literature Review of Gastric Outlet Obstruction trials Research Report on Gastric Outlet Obstruction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of TAS1553 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia (AML) and Other Myeloid Neoplasms TAS1553 - Acute Myeloid Leukemia, Myeloproliferative Neoplasm | Phase 1 | Terminated | Astex Pharmaceuticals, Inc. | 20 | 2020-12-21 | 2024-08-02 |
| Prophylactic Ethanol Lock Therapy (ELT) in Patients on Home Parenteral Nutrition Ethanol, Heparin Lock, Normal Saline - Catheter-related Bloodstream Infection (CRBSI) Nos, Bloodstream Infection Due to Central Venous Catheter | Phase 1 / Phase 2 | Terminated | Mayo Clinic | 39 | 2014-07-01 | 2017-12-12 |
| Multiple Ascending Dose of BMS-911543 BMS-911543 - Cancer | Phase 1 / Phase 2 | Terminated | Bristol-Myers Squibb | 98 | 2011-04-07 | 2019-07-31 |
Pyloric Stenosis, Hypertrophic (3) · Leukemia, Myeloid, Acute (1) · Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative (1) · Leukemia, Myelomonocytic, Chronic (1) · Leukemia, Neutrophilic, Chronic (1) · Myelodysplastic-Myeloproliferative Diseases (1) · Myeloproliferative Disorders (1) · Neoplasms (1) · Pdgfra-Associated Chronic Eosinophilic Leukemia (1) · Polycythemia Vera (1) · Primary Myelofibrosis (1) · Thrombocythemia, Essential (1) · Thrombocytosis (1)
Digestive System Diseases (3) · Gastrointestinal Diseases (3) · Pyloric Stenosis (3) · Stomach Diseases (3) · Blood Coagulation Disorders (1) · Blood Platelet Disorders (1) · Bone Marrow Diseases (1) · Bone Marrow Neoplasms (1) · Chronic Disease (1) · Disease Attributes (1) · Hematologic Diseases (1) · Hematologic Neoplasms (1) · Hemic and Lymphatic Diseases (1) · Hemorrhagic Disorders (1)
Ethanol (1) · Heparin (1) · N,N-dicyclopropyl-4-((1,5-dimethyl-1H-pyrazol-3-yl)amino)-6-ethyl-1-methyl-1,6-dihydroimidazo(4,5-d)pyrrolo(2,3b)pyridine-7-carboxamide (1) · Saline Solution (1) · Vascular Access Devices (1)
Astex Pharmaceuticals, Inc. (1) · Bristol-Myers Squibb (1) · Mayo Clinic (1)
United States (3) · Australia (1) · Canada (1)